Aardvark Therapeutics, Inc.

AARD·NASDAQ·$4.20Share Price as of 11/2·$92MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/23/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/13/25

Disclosures

8-KCurrent report10/23/26 8-KCurrent report10/22/26 8-KCurrent report10/08/26 8-KCurrent report08/17/26 8-KCurrent report08/11/26

Prospectuses and Registrations

424B5Prospectus supplement04/03/26 S-8Registration of securities for employees03/24/26 S-3Shelf registration03/23/26 S-8Registration of securities for employees08/13/25 424B4Prospectus02/13/25

Proxies

DEF 14ADefinitive proxy07/10/26 PRE 14APreliminary proxy06/29/26

Ownership

Form 3Initial insider ownership10/08/26 Form 4Insider transaction10/08/26 144Proposed sale of securities09/11/26 Form 4Insider transaction09/11/26 144Proposed sale of securities09/10/26

Other

ARSAnnual report to shareholders07/10/26 EFFECTRequest for effectiveness04/03/26 CORRESPCorrespondence with the SEC03/30/26 UPLOADLetter from the SEC03/25/26 CERTCEO/CFO certification02/12/25